Evidence map›Paper›PMID 32328300›Full record

ArticleInternational journal of hypertension2020

Hypertension Subtypes among Thai Hypertensives: An Analysis of Telehealth-Assisted Instrument in Home Blood Pressure Monitoring Nationwide Pilot Project.

Sakolwat Montrivade, Pairoj Chattranukulchai, Sarawut Siwamogsatham, Yongkasem Vorasettakarnkij, Witthawat Naeowong, Patchaya Boonchayaanant, Anut Sakulsupsiri, Aekarach Ariyachaipanich, Vorarit Lertsuwunseri, Voravut Rungpradubvong and 11 more

Open access · goldAbstract read
In one paragraph

Article in International journal of hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Prevalence of hypertension and related factors among suspected hypertensive medical personnel during COVID-19 vaccination.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  5. Article
  6. May Measurement Month 2021: an analysis of blood pressure screening results from Thailand.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  7. Review
  8. 2022 Thai Hypertension Society guidelines on home blood pressure monitoring.Journal of clinical hypertension (Greenwich, Conn.) · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Sakolwat MontrivadeDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Pairoj ChattranukulchaiDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.ORCID https://orcid.org/0000-0001-6153-8398
Sarawut SiwamogsathamDivision of Hospital and Ambulatory Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.ORCID https://orcid.org/0000-0001-5747-6585
Yongkasem VorasettakarnkijDivision of Hospital and Ambulatory Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Witthawat NaeowongDivision of Hospital and Ambulatory Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Patchaya BoonchayaanantDivision of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.ORCID https://orcid.org/0000-0003-3502-905X
Anut SakulsupsiriPharmacy Department, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Aekarach AriyachaipanichDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Vorarit LertsuwunseriDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Voravut RungpradubvongDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Sudarat SatitthummanidDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Sarinya PuwanantDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Somchai PrechawatDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Suphot SrimahachotaDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Jarkarpun ChaipromprasitDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Wacin BuddhariDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Smonporn BoonyaratavejDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Surapun SitthisookDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Peera BuranakitjaroenDepartment of Medicine, Siriraj Hospital, Mahidol University, 10700 Bangkok, Thailand.
Apichard SukonthasarnThai Hypertension Society, 10310 Bangkok, Thailand.
Somkiat SangwatanarojDivision of Cardiovascular Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 10330 Bangkok, Thailand.
Chulalongkorn University · THKing Chulalongkorn Memorial Hospital · THSiriraj Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhite-coat hypertension (HT), masked HT, HT with white-coat effect, and masked uncontrolled HT are well-recognized problems of over- and undertreatment of high blood pressure in real-life practice. However, little is known about the true prevalence in Thailand.

objectivesTo examine the prevalence and characteristics of each HT subtype defined by mean home blood pressure (HBP) and clinic blood pressure (CBP) using telemonitoring technology in Thai hypertensives.

methodsA multicenter, observational study included adult hypertensives who had been diagnosed for at least 3 months based on CBP without the adoption of HBP monitoring. All patients were instructed to manually measure their HBP twice a day for the duration of at least one week using the same validated automated, oscillometric telemonitoring devices (Uright model TD-3128, TaiDoc Corporation, Taiwan). The HBP, CBP, and baseline demographic data were recorded on the web-based system. HT subtypes were classified according to the treatment status, CBP (≥or <140/90 mmHg), and mean HBP (≥or <135/85 mmHg) into the following eight subtypes: in nonmedicated hypertensives, there are four subtypes that are normotension, white-coat HT, masked HT, and sustained HT; in treated hypertensives, there are four subtypes that are well-controlled HT, HT with white-coat effect, masked uncontrolled HT, and sustained HT.

resultsOf the 1,184 patients (mean age 58 ± 12.7 years, 59% women) from 46 hospitals, 1,040 (87.8%) were taking antihypertensive agents. The majority of them were enrolled from primary care hospitals (81%). In the nonmedicated group, the prevalence of white-coat and masked HT was 25.7% and 7.0%, respectively. Among the treated patients, the HT with white-coat effect was found in 23.3% while 46.7% had uncontrolled HBP (a combination of the masked uncontrolled HT (9.6%) and sustained HT (37.1%)). In the medicated older subgroup (

conclusionsThis is the first nationwide study in Thailand to examine the prevalence of HT subtypes. Almost one-fourth had white-coat HT or HT with white-coat effect. Approximately half of the treated patients especially in the older males had uncontrolled HBP requiring more intensive interventions. These results emphasize the role of HBP monitoring for appropriate HT diagnosis and management. The cost-effectiveness of utilizing THAI HBPM in routine practice needs to be examined in the future study.

Identifiers

PMID32328300
PMCPMC7171656
OpenAlexW3015294676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.